首页> 外文期刊>Drug Metabolism and Disposition: The Biological Fate of Chemicals >Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes.
【24h】

Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes.

机译:美托咪定的区域和立体特异性N-葡萄糖醛酸苷化:UDP葡萄糖醛酸糖基转移酶(UGT)1A4和UGT2B10之间的差异解释了人类肝微粒体的复杂动力学。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Medetomidine is a chiral imidazole derivate whose dextroenantiomer is pharmacologically active. The major metabolic pathway of dexmedetomidine [(+)-4-(S)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole] in humans is N-glucuronidation at the imidazolate nitrogens. We have purified the N3- and N1-glucuronides of dexmedetomidine, termed DG1 and DG2, respectively, according to their elution order in liquid chromatography and determined their structure by 1H nuclear magnetic resonance (NMR). Studying medetomidine glucuronidation by human liver microsomes (HLMs) and recombinant UDP glucuronosyltransferase (UGT) 1A4 indicated that another human UGT plays a major role in these activities. We now demonstrate that this enzyme is UGT2B10. HLMs catalyzed DG1 and DG2 formation, at a ratio of 3:1, with two-enzyme kinetics that contain both a high-affinity component, K(m1) values of 6.6 and 8.7 microM, and a low-affinity component, K(m2) values > 1 mM. The DG1/DG2 ratio in the case of UGT2B10 was lower, 1.4:1, whereas thesubstrate affinity for both reactions was high, K(m) values of 11 and 16 microM. UGT1A4 produced mainly DG1 (DG1/DG2 ratio of 6.6:1) at low substrate affinities, K(m) values above 0.6 mM, but superior expression-normalized V(max) values. Levomedetomidine [(-)-4-(R)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole] glucuronidation by HLMs yielded mostly the N3-glucuronide (LG1, structure determined by NMR), with monophasic kinetics and a K(m) value of 14 microM. The activity of UGT1A4 toward levomedetomide was low and generated both LG1 and LG2, whereas UGT2B10 exhibited relatively high activity and sharp regioselectivity, yielding only LG1, with a K(m) value of 7.4 microM. The results highlight the contribution of UGT2B10 to medetomidine glucuronidation and its potential importance for other N-glucuronidation reactions within the human liver.
机译:美托咪定是一种手性咪唑衍生物,其右旋对映体具有药理活性。右美托咪定[(+)-4-(S)-[1-(2,3-二甲基苯基)乙基] -1H-咪唑]在人体内的主要代谢途径是在咪唑氮上的N-葡萄糖醛酸化。我们已根据其在液相色谱中的洗脱顺序,分别纯化了右美托咪定的N3-和N1-葡糖醛酸苷,分别称为DG1和DG2,并通过1H核磁共振(NMR)确定了其结构。对人肝微粒体(HLM)和重组UDP葡萄糖醛酸转移酶(UGT)1A4的美托咪定葡萄糖醛酸苷化的研究表明,另一种人类UGT在这些活动中起主要作用。现在我们证明该酶是UGT2B10。 HLM以3:1的比例催化DG1和DG2的形成,并且两种酶动力学都包含高亲和力组分K(m1)值分别为6.6和8.7 microM和低亲和力组分K(m2) )值> 1 mM。在UGT2B10的情况下,DG1 / DG2比率较低,为1.4:1,而对两种反应的底物亲和力均较高,K(m)值为11和16 microM。 UGT1A4主要在低底物亲和力,K(m)值高于0.6 mM的情况下主要产生DG1(DG1 / DG2比为6.6:1),但具有较高的表达归一化V(max)值。左美托咪定[(-)-4-(R)-[1-(2,3-二甲基苯基)乙基] -1H-咪唑]葡萄糖醛酸苷化主要产生N3-葡萄糖醛酸苷(LG1,由NMR确定的结构),具有单相动力学K(m)值为14 microM。 UGT1A4的抗左美托体活性低,并同时生成LG1和LG2,而UGT2B10表现出相对较高的活性和强烈的区域选择性,仅产生LG1,K(m)值为7.4 microM。结果突出了UGT2B10对美托咪定葡糖醛酸化的贡献及其对人肝脏内其他N-葡糖醛酸化反应的潜在重要性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号